PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹968 Cr | ₹660 Cr | ₹257 Cr | ₹356 Cr | ₹667 Cr |
What is the latest Cash Flow from Operating Activities ratio of PFIZER ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹968 Cr |
| Mar2025 | ₹660 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹356 Cr |
| Mar2022 | ₹667 Cr |
How is Cash Flow from Operating Activities of PFIZER Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹968 Cr | 46.66 | |
| Mar2025 | ₹660 Cr | 156.87 | |
| Mar2024 | ₹257 Cr | -27.79 | |
| Mar2023 | ₹356 Cr | -46.68 | |
| Mar2022 | ₹667 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,928.2 Cr | -3.3% | 1.4% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -3.3% |
1.4% |
-14.4% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses